BioVentrix Completes Enrollment in Pilot Human Clinical Trial of the PliCath ... MarketWatch (press release) The PliCath HF system is designed to treat the most common type of heart failure (HF) by restoring a more normal geometry to an enlarged, scarred heart. This effect is accomplished by exclusion from the left ventricle (LV) of non-contracting scar ... |
